Evidence for relative cortical sparing in benign multiple sclerosis: A longitudinal magnetic resonance imaging study

Multiple Sclerosis

Volumn 15, Issue 1, 2009, Pages 36-41

  Calabrese, M ^a   Filippi, Massimo ^b   Rovaris, M ^b   Bernardi, V ^a   Atzori, M ^a   Mattisi, I ^a   Favaretto, A ^a   Grossi, P ^a   Barachino, L ^c   Rinaldi, L ^a   Romualdi, C ^d   Perini, P ^a   Gallo, P ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c Neuroradiology Unit   (Italy)

^d UNIVERSITY OF PADOVA   (Italy)

Author keywords

Cortical lesions; Double inversion recovery sequence; Multiple sclerosis

Indexed keywords

BETA1A INTERFERON; GLATIRAMER; METHYLPREDNISOLONE;

ADULT; ARTICLE; BENIGN MULTIPLE SCLEROSIS; BRAIN CORTEX LESION; CONTROLLED STUDY; DEMYELINATING DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; EXPANDED DISABILITY STATUS SCALE; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; RELAPSE; WHITE MATTER;

ADULT; CEREBRAL CORTEX; DISABILITY EVALUATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

EID: 58149095079     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458508096686     Document Type: Article

References (36)

1. Noseworthy JH Lucchinetti C Rodriguez M Weinshenker BG. Multiple Sclerosis. N Engl J Med 2000; 343: 938-852 [Review].
2. Hawkins SA McDonnell GV. Benign multiple sclerosis? Clinical course, long term follow up, and assessment of prognostic factors. J Neurol Neurosurg Psychiatry 1999; 67: 148-152.
3. Ramsaransing GS De Keyser J. Benign course in multiple sclerosis: A review. Acta Neurol Scand 2006; 113: 359-369 [Review].
4. Lublin FD Reingold SC. Defining the clinical course of multiple sclerosis: Results of an international survey. Neurology 1996; 46: 907-911.
5. Ramsaransing G Maurits N Zwanikken C De KJ. Early prediction of a benign course of multiple sclerosis on clinical grounds: A systematic review. Mult Scler 2001; 7: 345-347.
6. Peterson JW Bo L Mork S Chang A Trapp BD. Transected neurites, apoptotic neurons and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 2001; 50: 389-400.
7. Kidd D Barkhof F McConnel R Algra PR Allen IV Revesz T. Cortical lesions in multiple sclerosis. Brain 1999; 122: 17-26.
8. Bo L Vedeler CA Nyland HI Trapp BD Mork SJ. Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J Neuropathol Exp Neurol 2003; 62: 723-732.
9. Kutzelnigg A Lucchinetti CF Stadelmann C. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005; 128: 2705-2712.
10. Dalton CM Chard DT Davies GR. Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. Brain 2004; 127: 1101-1107.
11. Chard DT Griffin CM McLean MA. Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis. Brain 2002; 125: 2342-2352.
12. Calabrese M Atzori M Bernardi V. Cortical atrophy is relevant in multiple sclerosis at clinical onset. J Neurol 2007; 254: 1212-1220.
13. Chen JT Narayanan S Collins DL Smith SM Matthews PM Arnold DL. Relating neocortical pathology to disability progression in multiple sclerosis using MRI. NeuroImage 2004; 23: 1168-1175.
14. Pagani E Rocca MA Gallo A. Regional brain atrophy evolves differently in patients with multiple sclerosis according to clinical phenotype. AJNR Am J Neuroradiol 2005; 26: 341-346.
15. Rovaris M Filippi M Minicucci L. Cortical/subcortical disease burden and cognitive impairment in patients with multiple sclerosis. AJNR Am J Neuroradiol 2000; 21: 402-408.
16. Portaccio E Amato MP Bartolozzi ML. Neocortical volume decrease in relapsing-remitting multiple sclerosis with mild cognitive impairment. J Neurol Sci 2006; 245: 195-199.
17. Geurts JJ Bo L Pouwels PJ Castelijns JA Polman CH Barkhof F. Cortical lesions in multiple sclerosis: Combined postmortem MR imaging and histopathology. AJNR Am J Neuroradiol 2005; 26: 572-577.
18. Geurts JJ Pouwels PJ Uitdehaag BM Polman CH Barkhof F Castelijns JA. Intracortical lesions in multiple sclerosis: Improved detection with 3D double inversion-recovery MR imaging. Radiology 2005; 236: 254-260.
19. Calabrese M De Stefano N Atzori M. Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis. Arch Neurol 2007; 64: 1416-1422.
20. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 1983; 33: 1444-1452.
21. Poser CM Paty DW Scheinberg LC. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 1983; 13: 227-231.
22. Amato MP Portaccio E Goretti B. The Rao's Brief Repeatable Battery and Stroop Test: Normative values with age, education and gender corrections in an Italian population. Mult Scler 2006; 12: 787-793.
23. Benjamini Y Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc Ser B 1995; 57: 289-300.
24. Pittock SJ McClelland RL Mayr WT. Clinical implications of benign multiple sclerosis: A 20-year population-based follow-up study. Ann Neurol 2004; 56: 303-306.
25. Sayao AL Devonshire V Tremlett H. Longitudinal follow-up of "benign" multiple sclerosis at 20 years. Neurology 2007; 68: 496-500.
26. Rugg-Gunn FJ Boulby PA Symms MR Barker GJ Duncan JS. Imaging the neocortex in epilepsy with double inversion recovery imaging. Neuroimage 2006; 31: 39-50.
27. Cotton F Rambaud L Hermier M. Dual inversion recovery MRI helps identifying cortical tubers in tuberous sclerosis. Epilepsia 2006; 47: 1072-1073.
28. Nelson F Poonawalla AH Hou P Huang F Wolinsky JS Narayana PA. Improved identification of intracortical lesions in multiple sclerosis with phase-sensitive inversion recovery in combination with fast double inversion recovery MR imaging. AJNR Am J Neuroradiol 2007; 28: 1645-1649.
29. De Stefano N Battaglini M Stromillo ML. Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis. Brain 2006; 129: 2008-2016.
30. Pirko I Lucchinetti CF Sriram S Bakshi R. Grey matter involvement in multiple sclerosis. Neurology 2007; 68: 634-642.
31. Strasser-Fuchs S Enzinger C Ropele S Wallner M Fazekas F. Clinically benign multiple sclerosis despite large T2 lesion load: Can we explain this paradox. Mult Scler 2008; 14: 205-211.
32. Rovaris M Judica E Gallo A. Grey matter damage predicts the evolution of primary progressive multiple sclerosis at 5 years. Brain 2006; 129: 2628-2634.
33. Agosta F Rovaris M Pagani E Sormani MP Comi G Filippi M. Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis. Brain 2006; 129: 2620-2627.
34. Rocca MA Filippi M. Functional MRI to study brain plasticity in clinical neurology. Neurol Sci 2006; 27 (Suppl. 1): S24-S26.
35. Rocca MA Filippi M. Functional MRI in multiple sclerosis. J Neuroimaging 2007; 17(Suppl. 1): 36S-41S.
36. Ceccarelli A Rocca MA Pagani E. The topographical distribution of tissue injury in benign MS: A 3T multiparametric MRI study. NeuroImage 2008; 39: 1499-1509.